111 related articles for article (PubMed ID: 19889795)
1. Inhibition of dystrophin breakdown and endothelial nitric-oxide synthase uncoupling accounts for cytoprotection by 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e) in left ventricular hypertrophied Mice.
Han F; Lu YM; Hasegawa H; Kanai H; Hachimura E; Shirasaki Y; Fukunaga K
J Pharmacol Exp Ther; 2010 Feb; 332(2):421-8. PubMed ID: 19889795
[TBL] [Abstract][Full Text] [Related]
2. Phenylephrine-induced cardiomyocyte injury is triggered by superoxide generation through uncoupled endothelial nitric-oxide synthase and ameliorated by 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxyindazole (DY-9836), a novel calmodulin antagonist.
Lu YM; Han F; Shioda N; Moriguchi S; Shirasaki Y; Qin ZH; Fukunaga K
Mol Pharmacol; 2009 Jan; 75(1):101-12. PubMed ID: 18952768
[TBL] [Abstract][Full Text] [Related]
3. DY-9760e, a novel calmodulin inhibitor, exhibits cardioprotective effects in the ischemic heart.
Fukunaga K; Han F; Shioda N; Moriguchi S; Kasahara J; Shirasaki Y
Cardiovasc Drug Rev; 2006; 24(2):88-100. PubMed ID: 16961723
[TBL] [Abstract][Full Text] [Related]
4. 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, reduces brain edema through the inhibition of enhanced blood-brain barrier permeability after transient focal ischemia.
Sato T; Morishima Y; Shirasaki Y
J Pharmacol Exp Ther; 2003 Mar; 304(3):1042-7. PubMed ID: 12604680
[TBL] [Abstract][Full Text] [Related]
5. Microsphere embolism-induced endothelial nitric oxide synthase expression mediates disruption of the blood-brain barrier in rat brain.
Han F; Shirasaki Y; Fukunaga K
J Neurochem; 2006 Oct; 99(1):97-106. PubMed ID: 16987238
[TBL] [Abstract][Full Text] [Related]
6. 3-[2-[4-(3-Chloro-2-methylphenylmethyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydro-chloride 3.5 hydrate (DY-9760e) is neuroprotective in rat microsphere embolism: role of the cross-talk between calpain and caspase-3 through calpastatin.
Han F; Shirasaki Y; Fukunaga K
J Pharmacol Exp Ther; 2006 May; 317(2):529-36. PubMed ID: 16467455
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotective effect of 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e) against ischemia/reperfusion-induced injury in rat heart involves inhibition of fodrin breakdown and protein tyrosine nitration.
Hashimoto M; Takada Y; Takeuchi Y; Kasahara J; Hisa H; Shirasaki Y; Fukunaga K
J Pharmacol Sci; 2005 Jun; 98(2):142-50. PubMed ID: 15937403
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neuronal nitric oxide synthase activity by 3-[2-[4-(3-chloro-2-methylphenyl)- 1-piperazinyl]ethyl]-5, 6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel neuroprotective agent, in vitro and in cultured neuroblastoma cells in situ.
Fukunaga K; Ohmitsu M; Miyamoto E; Sato T; Sugimura M; Uchida T; Shirasaki Y
Biochem Pharmacol; 2000 Sep; 60(5):693-9. PubMed ID: 10927028
[TBL] [Abstract][Full Text] [Related]
9. The neuroprotective effect of a novel calmodulin antagonist, 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate, in transient forebrain ischemia.
Hashiguchi A; Kawano T; Yano S; Morioka M; Hamada J; Sato T; Shirasaki Y; Ushio Y; Fukunaga K
Neuroscience; 2003; 121(2):379-86. PubMed ID: 14521996
[TBL] [Abstract][Full Text] [Related]
10. Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats.
Bhuiyan MS; Shioda N; Fukunaga K
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1606-14. PubMed ID: 17878225
[TBL] [Abstract][Full Text] [Related]
11. The post-ischemic administration of 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, prevents delayed neuronal death in gerbil hippocampus.
Hashiguchi A; Yano S; Morioka M; Hamada J; Shirasaki Y; Kochi M; Fukunaga K
J Pharmacol Sci; 2004 Sep; 96(1):65-72. PubMed ID: 15359085
[TBL] [Abstract][Full Text] [Related]
12. DY-9760e, a novel calmodulin antagonist, reduces infarction after permanent focal cerebral ischemia in rats.
Sato T; Takamori H; Shirasaki Y
Pharmacology; 2004 May; 71(1):38-45. PubMed ID: 15051921
[TBL] [Abstract][Full Text] [Related]
13. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
14. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
[TBL] [Abstract][Full Text] [Related]
16. Post-ischemic administration of DY-9760e, a novel calmodulin antagonist, reduced infarct volume in the permanent focal ischemia model of spontaneously hypertensive rat.
Takagi K; Sato T; Shirasaki Y; Narita K; Tamura A; Sano K
Neurol Res; 2001 Sep; 23(6):662-8. PubMed ID: 11547940
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and disposition of DY-9760e, a novel calmodulin antagonist, in rats and monkeys.
Tachibana S; Fujimaki Y; Tachibana M; Tanaka M; Kurata T; Okazaki O; Sudo K
Arzneimittelforschung; 2005; 55(3):135-44. PubMed ID: 15819385
[TBL] [Abstract][Full Text] [Related]
18. DY-9760e, a calmodulin antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.
Sugimura M; Takamori H; Fukushi H; Kitano Y; Kanazawa Y; Shirasaki Y
Biol Pharm Bull; 2005 Apr; 28(4):629-33. PubMed ID: 15802800
[TBL] [Abstract][Full Text] [Related]
19. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
20. DY-9760e, a novel calmodulin antagonist, reduces brain damage induced by transient focal cerebral ischemia.
Sato T; Morishima Y; Sugimura M; Uchida T; Shirasaki Y
Eur J Pharmacol; 1999 Apr; 370(2):117-23. PubMed ID: 10323259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
